HDM201 Added to CT in R/R or Newly Diagnosed AML

Clinical trial NCT03760445 · WITHDRAWN

Trial details

NCT number: NCT03760445
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2019-11-15
Primary completion: 2021-07-22
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.